Israel Active

Researchers at Israel’s Clalit Research Institute & Rabin Medical Center (Beilinson) have discovered that the gene TRIM63 is a major genetic driver and risk factor for hypertrophic cardiomyopathy (HCM), the world’s most common hereditary heart disease. Screening could save many lives.

Researchers from the Hebrew University of Jerusalem and the IDF's Medical Corps have discovered a peptide to activate Protein Kinase C-epsilon (PKC-ε) and significantly improve survival rates of patients (including wounded soldiers) who suffer massive blood loss.

Blackstone Investment firm president Jonathan Gray and his wife Mindy are donating $125 million to Tel Aviv University's Faculty of Medicine - the largest donation in the university's history - to increase the number of doctors in Israel. The faculty will now bear the couple's name.

US ambassador Mike Huckabee received a United Hatzalah Defender of Israel Award at a special celebration for the Israel's emergency response organization at the Museum of Tolerance Jerusalem. He recounted the time when a UH responder saved the life of one of the delegates of a mission he was leading.

Scientists at the Hebrew University of Jerusalem have discovered that the protein CsrA in bacteria creates a “control center” inside a cell that manages the activation of disease-causing genes. Future treatments that disable the control center should stop infections before they take hold.

Researchers from Israel’s Bar-Ilan University have analyzed the differences in protein sequences across mammals with varying lifespans. They discovered that long-lived whales and humans have specific post-translational modifications (PTMs) that may protect against age-related diseases (e.g. cancer).

During the Covid-19 epidemic, Professor Yonina Eldar of Israel’s Weizmann Institute led the development of radar technology to remotely check health. Her lab has unveiled BRAHMS, the Bio-Radar Health Monitoring System which uses AI to analyze subtle chest movements.

Israel’s CardioVia has just received U.S. FDA clearance for its ViaOne system. It provides safe (no needle) access to the pericardium – the thin sac protecting the heart where new minimally invasive treatments are having much success over conventional, risky, heart surgery.

Israel’s Inspira Technologies (see previously) used its INSPIRA ART100 system at Westchester Medical Center, New York to circulate and oxygenate a patient’s blood. It marked the first real-world implementation of Inspira's innovative life-support technology.

Ben-Gurion University researchers have developed WGAND - an AI algorithm that can detect "anomalous" proteins that are associated with tissue-specific diseases. It involves "anomalous" behavior analysis, similar to methods that identify fraudulent financial transactions or suspicious user activity.